North America Psychedelic Drugs Market to 2032
Overview
The North America Psychedelic Drugs Market is expected to reach a 10,152.24 USD Billion by 2032 and is projected to grow at a CAGR of 17.31% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3,738.06
Forecast, 2032 (USD Billion)
10,152.24
CAGR, 2024 - 2032
17.31%
Report Coverage
North America
North America Psychedelic Drugs Market 2018-2032 USD Billion
North America Psychedelic Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3,738.06 USD Billion
- Projected Market Size (2032): 10,152.24 USD Billion
- CAGR (2025-2032): 17.31%
Key Findings of North America Psychedelic Drugs Market
- The North America Psychedelic Drugs Market was valued at 3,738.06 USD Billion in 2024.
- The North America Psychedelic Drugs Market is likely to grow at a CAGR of 17.31% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Synthetic in Source Segment accounted for the largest share of the market with a revenue of 3,738.06 USD Billion
- The fastest growing segment Post-Traumatic Stress Disorder in Application Segment grew Fastest with a CAGR of 20.80% during the forecast period from 2024 to 2032.
North America Psychedelic Drugs Market Scope
North America Psychedelic Drugs Market Segmentation & Scope
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Application
- Others
- Post-Traumatic Stress Disorder
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
North America Psychedelic Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3,738.06 USD Billion |
| Market Value in 2032 | 10,152.24 USD Billion |
| CAGR (2025-2032) | 17.31% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Source,Type,Drugs,Application,Route of Administration,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 3,738.06 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 3,714.60 USD Billion in 2024.
Segments and Scope
-
North America Psychedelic Drugs Market to 2032, By Source
- Synthetic is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 3,738.06 USD Billion in the year 2024.
- Synthetic is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 17.31 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By Type
- Empathogens is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,830.33 USD Billion in the year 2024.
- Empathogens is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 17.79 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By Drugs
- Gamma-Hydroxybutyric Acid is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,826.70 USD Billion in the year 2024.
- Ketamine is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 17.18 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By Application
- Narcolepsy is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,281.44 USD Billion in the year 2024.
- Post-Traumatic Stress Disorder is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 16.55 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By Route of Administration
- Oral is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,918.10 USD Billion in the year 2024.
- Oral is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 18.30 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By End User
- Hospitals is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,190.10 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 18.01 % in forecast period 2025-2032.
-
North America Psychedelic Drugs Market to 2032, By Distribution Channel
- Hopitals Pharmacy is the largest segment in North America Psychedelic Drugs Market to 2032 with a revenue of 2,584.32 USD Billion in the year 2024.
- Hopitals Pharmacy is the Fastest growing segment in North America Psychedelic Drugs Market to 2032 with a Growth rate of 18.05 % in forecast period 2025-2032.
North America Psychedelic Drugs Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Jazz Pharmaceuticals, Inc. | |||
| Janssen Global Services, LLC | |||
| ICU Medical, Inc. | |||
| Stryker | |||
North America Psychedelic Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
North America Psychedelic Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Psychedelic Drugs Market is segmented based on Segmentation Source,Type,Drugs,Application,Route of Administration,End User,Distribution Channel.
North America Psychedelic Drugs Market was valued at USD 3,738.06(Revenue in USD Billion) in 2022.
North America Psychedelic Drugs Market is projected to grow at a CAGR of 17.31% during the forecast period of 2024 to 2032.
The Synthetic segment is expected to dominate the North America Psychedelic Drugs Market, holding a largest market share of 3,738.06 USD Billion in 2024
North America Psychedelic Drugs Market Scope
North America Psychedelic Drugs Market Segmentation & Scope
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Application
- Others
- Post-Traumatic Stress Disorder
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
Frequently Asked Questions
The North America Psychedelic Drugs Market is segmented based on Segmentation Source,Type,Drugs,Application,Route of Administration,End User,Distribution Channel.
North America Psychedelic Drugs Market was valued at USD 3,738.06(Revenue in USD Billion) in 2022.
North America Psychedelic Drugs Market is projected to grow at a CAGR of 17.31% during the forecast period of 2024 to 2032.
The estimated market value of the North America Psychedelic Drugs Market for final year is USD 10,152.24 (USD Billion).
North America Psychedelic Drugs Market Company Profiling
Frequently Asked Questions
The North America Psychedelic Drugs Market is segmented based on Segmentation Source,Type,Drugs,Application,Route of Administration,End User,Distribution Channel.
North America Psychedelic Drugs Market was valued at USD 3,738.06(Revenue in USD Billion) in 2022.
North America Psychedelic Drugs Market is projected to grow at a CAGR of 17.31% during the forecast period of 2024 to 2032.
The estimated market value of the North America Psychedelic Drugs Market for final year is USD 10,152.24 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.